Kenya Medical Device Import Permits: CoC First, Then Single Window
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
Content verified on: October 30, 2026
1. Key takeaways
- The order cannot be reversed: importers must first obtain a Certificate of Conformity (CoC) and then apply to PPB for an import licence through the KenTrade Single Window System.
- The legal basis of the single window is the National Electronic Single Window System Act (Cap. 485D).
- Every consignment requires a separate licence; there is no room for one licence covering multiple clearances.
- Medical devices fall within the scope of the Pre-Export Verification of Conformity (PVoC) programme, covering medical equipment and surgical instruments.
- Personal-use imports need no establishment registration, but PPB import authorisation is still required; a registration certificate does not by itself substitute for an import licence.
2. Legal basis
| Instrument | Reference / number | Date made / effective | Provisions | Points relevant to this article |
|---|---|---|---|---|
| National Electronic Single Window System Act | Cap. 485D | — | Whole document | Legal basis of the single window system; import licences are submitted to PPB through it |
| Standards Act | Cap. 496 | — | — | Functions of KEBS and the legal basis of the PVoC programme |
| KEBS Pre-Export Verification of Conformity Legal Notice | LN 78 of 2020 (amended by LN 212 and LN 53) | April 28, 2020 (amendments dated December 18, 2020 and April 22, 2021) | — | Current legal basis of PVoC; medical devices are within the regulated scope; the CoC is a precondition document |
| Pharmacy and Poisons (Registration of Health Products and Technologies) Rules, 2022 | Legal Notice No. 100 of 2022 | Made June 8, 2022 | Regulations 3, 5(4) | Unregistered products may not be imported; prior licence requirement for licence holders |
| Guidelines for Registration of Medical Devices Establishments | PRA/LPP/GUD/072 | — | Whole document | No import or distribution without an establishment registration certificate; personal-use imports require PPB import authorisation |
3. Expert insights
Insight 1: The sequence of three documents forms one chain of evidence, not three parallel formalities
The CoC proves that the goods conform to Kenyan standards; the PPB import licence proves that the product has been cleared to enter the market; and the single window is the channel through which both are submitted and converge. GRZAN notes that every link in this chain cites the information of the previous one — the product name, model, batch number and manufacturer in the import licence application must match the CoC and the registration certificate exactly. Any single inconsistency gets amplified at customs clearance into a return or detention risk, at a moment when supply contracts, vessel schedules and hospital clinical calendars are already locked in.
Insight 2: Consignment-by-consignment licensing is a hard constraint on supply planning
Because every consignment needs a separate licence, import plans cannot be filed as an annual volume; they must be processed shipment by shipment. GRZAN recommends embedding the licence lead time as a fixed pre-stage in the sales and operations planning (S&OP) process. For cold-chain and shelf-life-sensitive products in particular, the licence processing time stacked on top of transport time can compress the sellable window dramatically, so the fixed lead time must be protected in planning rather than absorbed as an afterthought.
Insight 3: The single window is a data convergence point and naturally connects to traceability
The single window under Cap. 485D concentrates import declarations, licence approval and inspection data at one entry point. With the National Authentication and Traceability System live from August 3, 2026 and a planned transition to full serialization on January 1, 2027, the batch and product data captured at import become the origin of the traceability chain. GRZAN judges that the data definitions used in single window declarations should be maintained in one master dataset with packaging labels and internal batch ledgers, so that two divergent sets of data never form.
Insight 4: Registered does not mean importable
A registration certificate answers whether a product may be sold in Kenya; an import licence answers whether this particular consignment may enter the country. They belong to different procedures. GRZAN notes two further layers of constraint: the entity — the importer must hold an establishment registration certificate (personal use excepted, subject to PPB import authorisation) — and the goods, which must first have a CoC. If either is missing, even a registered product cannot complete customs clearance.
4. Practical recommendations
- Fix the sequence in scheduling. GRZAN recommends writing the sequence of PVoC application, then CoC issuance, then single window import licence, then shipment into a standard operating procedure, with no step skipped.
- Unify the data definitions. Product name, model, batch number and manufacturer name should draw on one master dataset across the CoC, registration certificate, single window declaration and packaging label.
- Keep a consignment ledger. For every shipment, record the application number, licence number, validity period and actual arrival in a licence ledger.
- Reserve lead time. Set licence processing as a fixed pre-stage in S&OP, with extra buffer for cold-chain and short-shelf-life products.
- Verify importer qualifications. Before commissioning an import, check the counterparty’s establishment registration certificate status and business scope.
- Retain the full document set. File the CoC, import licence and clearance documents by consignment, ready for retrospective PPB checks and market surveillance sampling.
5. Verification checklist
- □ Has the CoC-first-then-licence sequence been confirmed and written into internal procedures?
- □ Has the CoC been obtained and is it within its validity?
- □ Was the import licence applied for through the KenTrade single window (Cap. 485D) per consignment?
- □ Does the importer hold a valid establishment registration certificate?
- □ For personal-use imports, has PPB import authorisation been obtained separately?
- □ Are the data on the CoC, registration certificate, licence declaration and packaging label fully consistent?
- □ Does the consignment licence ledger record application numbers, licence numbers and actual arrivals?
- □ Are the CoC, import licence and clearance documents filed by consignment?
Regulatory information verified as of October 30, 2026.
In African markets, the GRZAN regulatory team focuses on jurisdictions such as Kenya, Nigeria, South Africa and Egypt and runs a verification mechanism built on primary regulatory sources: every regulatory conclusion it publishes relies solely on official gazettes, the original texts of regulator guidelines and public legal databases, each marked with a verification date. Any figure, timeline or amount that cannot be located in an official source is flagged as a practical estimate rather than an assumption.
GRZAN services cover: market access strategy and risk-classification assessment; preparation and review of registration dossiers (CSDT, STED and CTD formats); selection and management of Local Authorized Representatives (LAR); quality management system and GMP/GSDP compliance coaching; post-market vigilance, change management and recall response; import customs clearance and PVoC coordination; regulatory intelligence subscriptions and corporate compliance ledgers.
For a Kenya market access plan tailored to a specific product, contact the GRZAN regulatory team at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us